(19)
(11) EP 3 645 012 A1

(12)

(43) Date of publication:
06.05.2020 Bulletin 2020/19

(21) Application number: 18823174.0

(22) Date of filing: 28.06.2018
(51) International Patent Classification (IPC): 
A61K 31/711(2006.01)
C12P 19/34(2006.01)
C12N 15/85(2006.01)
(86) International application number:
PCT/US2018/039980
(87) International publication number:
WO 2019/006107 (03.01.2019 Gazette 2019/01)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 28.06.2017 US 201762525787 P

(71) Applicant: University Of South Florida
Tampa, FL 33612 (US)

(72) Inventors:
  • NASH, Kevin Ron
    Temple Terrace Florida 33617 (US)
  • WEEBER, Edwin John
    Apollo Beach Florida 33572 (US)

(74) Representative: Cabinet Chaillot 
16/20, avenue de l'Agent Sarre B.P. 74
92703 Colombes Cedex
92703 Colombes Cedex (FR)

   


(54) MODIFIED UBE3A GENE FOR A GENE THERAPY APPROACH FOR ANGELMAN SYNDROME